A 15-month-old boy has become the youngest reported patient with Gaucher disease to develop multiple benign accumulations of Gaucher…
Articles by Jose Marques Lopes PhD
A €1.4 million grant from the Eurostars-2 program, with funding from others, will support Gain Therapeutics and its partners…
Plasma levels of a molecule called galactosylsphingosine are low enough that they do not interfere with the detection of the…
A new microscopy technique enables visualization of beta-glucocerebrosidase (GBA) given in enzyme replacement therapy (ERT) to people with Gaucher…
Modified versions of a compound already used in Gaucher disease research are more selective and potent blockers of the…
Adults with Gaucher disease type 1 (GD1) show a high prevalence of irreversible bone lesions, despite reaching treatment goals…
High activity of an enzyme called chitotriosidase (ChT) before treatment does not correlate with clinical or biochemical parameters in Gaucher…
Two approved treatments for Gaucher disease type 1 patients — Cerdelga (eliglustat) and Cerezyme (imiglucerase) — are equally…
Signs such as anemia or enlarged liver and spleen, and characteristics such as family history of Gaucher disease (GD) should…
A new case report describes a 14-year old boy diagnosed with Gaucher disease (GD) type 3 with retinal detachment in…